Edition:
United States

People: Orthofix International NV (OFIX.OQ)

OFIX.OQ on NASDAQ Stock Exchange Global Select Market

36.04USD
9:30am EST
Change (% chg)

$0.04 (+0.11%)
Prev Close
$36.00
Open
$36.04
Day's High
$36.04
Day's Low
$36.04
Volume
860
Avg. Vol
49,977
52-wk High
$48.19
52-wk Low
$32.56

Finegan, Michael 

Mr. Michael M. Finegan is Chief Strategy Officer of Orthofix International N.V., effective June 20, 2013. Mr. Finegan joined Orthofix International N.V. in June 2006 as Vice President of Corporate Development, and became the President, Biologics in March 2009. In October 2011, he was promoted to Senior Vice President, Business Development, and President, Biologics, and in June 2013, to his current position as Chief Strategy Officer. Prior to joining Orthofix, Mr. Finegan spent sixteen years as an executive with Boston Scientific in a number of different operating and strategic roles, most recently as Vice President of Corporate Sales. Earlier in his career, Mr. Finegan held sales and marketing roles with Marion Laboratories and spent three years in banking with First Union Corporation (Wachovia). Mr. Finegan earned a BA in Economics from Wake Forest University.

Basic Compensation

Total Annual Compensation, USD 814,002
Restricted Stock Awards, USD 402,375
Long-Term Incentive Plans, USD --
All Other, USD 150,887
Fiscal Year Total, USD 1,367,260

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ronald Matricaria

--

Bradley Mason

3,450,010

Doug Rice

525,232

Davide Bianchi

1,334,540

Michael Finegan

1,367,260

Luke Faulstick

--
As Of  30 Dec 2014